Drug Shortage Report for CEFTIN

Last updated on 2022-11-04 History
Report ID 172335
Drug Identification Number 02212307
Brand name CEFTIN
Common or Proper name cefuroxime axetil for oral suspension
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CEFUROXIME
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 70ML
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-19
Estimated end date
Actual end date 2022-10-28
Shortage status Resolved
Updated date 2022-11-04
Company comments This product has been divested.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-11-04 French Compare
v3 2022-11-04 English Compare
v2 2022-10-21 French Compare
v1 2022-10-21 English Compare

Showing 1 to 4 of 4